1.
Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study
by Kaplan, Hillard, Prof
The Lancet (British edition), 2017, Vol.389 (10080), p.1730-1739
2.
Atherosclerosis: current pathogenesis and therapeutic options
by Weber, Christian
Nature medicine, 2011, Vol.17 (11), p.1410-1422
3.
Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease
by Karpouzas, George A
Annals of the rheumatic diseases, 2014, Vol.73 (10), p.1797-1804
4.
Vitamin D deficiency and coronary artery disease: A review of the evidence
by Kunadian, Vijay, MBBS, MD, FRCP
The American heart journal, 2014, Vol.167 (3), p.283-291
5.
Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pre...
by Hoshide, Satoshi
Hypertension (Dallas, Tex. 1979), 2016, Vol.68 (1), p.54-61
6.
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
by Chen, Shaojie
Heart, 2013, Vol.99 (2), p.76-82
7.
Meta-Analysis of Mental Stress–Induced Myocardial Ischemia and Subsequent Cardiac Events in Patients With Coronary Artery Disease
by Wei, Jingkai, BMS
The American journal of cardiology, 2014, Vol.114 (2), p.187-192
8.
Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: A comprehensive exploration of plaque...
by Lee, Sang-Eun
The American heart journal, 2016, Vol.182, p.72-79
9.
Revisiting Fibromuscular Dysplasia: Rationale of the European Fibromuscular Dysplasia Initiative
by Persu, Alexandre
Hypertension (Dallas, Tex. 1979), 2016, Vol.68 (4), p.832-839
10.
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
by Shepherd, James
The Lancet (British edition), 2002, Vol.360 (9346), p.1623-1630
11.
Post-traumatic Stress Disorder, Coronary Atherosclerosis, and Mortality
by Ahmadi, Naser, MD, MS
The American journal of cardiology, 2011, Vol.108 (1), p.29-33
12.
Racial Differences in Abnormal Ambulatory Blood Pressure Monitoring Measures: Results From the Coronary Artery Risk Development in Young Adults (CARDIA) Study
by Muntner, Paul
American journal of hypertension, 2015, Vol.28 (5), p.640-648
13.
Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men
by ZANNI, Markella V
AIDS (London), 2013, Vol.27 (8), p.1263-1272
14.
From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
by Naghavi, Morteza
The American journal of cardiology, 2006, Vol.98 (2), p.2-15
15.
Human epicardial adipose tissue: A review
by Sacks, Harold S., MD
The American heart journal, 2007, Vol.153 (6), p.907-917
16.
Antiinflammatory effects of l -carnitine supplementation (1000 mg/d) in coronary artery disease patients
by Lee, Bor-Jen, M.D., Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2015, Vol.31 (3), p.475-479
17.
Why Have Antioxidants Failed in Clinical Trials?
by Steinhubl, Steven R., MD
The American journal of cardiology, 2008, Vol.101 (10), p.S14-S19
18.
Role of Asymmetrical Dimethylarginine in Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis
by Antoniades, Charalambos
Hypertension (Dallas, Tex. 1979), 2011, Vol.58 (1), p.93-98
19.
Impact of obesity on cardiac metabolism, fibrosis, and function
by Mahajan, Rajiv
Trends in cardiovascular medicine, 2015, Vol.25 (2), p.119-126
20.
Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients...
by Faergeman, Ole, MD, DMSc
The American journal of cardiology, 2009, Vol.104 (4), p.459-463
